Faouzia Ajili
Tunis, Tunisia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The efficiency of the EORTC scoring system for the prediction of recurrence and progression of non-muscle-invasive bladder cancer treated by bacillus Calmette-Guerin immunotherapy.
Journal: Ultrastructural pathology
Published: August 01, 2013
The efficacy of intravesical bacillus Calmette-Guerin in the treatment of patients with pT1 stage non-muscle-invasive bladder cancer.
Journal: Ultrastructural pathology
Published: June 25, 2013
The impact of age and clinical factors in non-muscle-invasive bladder cancer treated with Bacillus Calmette Guerin therapy.
Journal: Ultrastructural pathology
Published: May 03, 2013
Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.
Journal: Ultrastructural pathology
Published: February 07, 2013
Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy.
Journal: Ultrastructural pathology
Published: October 03, 2012
Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.
Journal: Ultrastructural pathology
Published: May 12, 2012
Prognostic value of Bcl-2 and Bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus Calmette-Guerin immunotherapy.
Journal: Ultrastructural pathology
Published: February 02, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026